Leu Agelii Monica, Hafström Ingiäld, Svensson Björn, Ajeganova Sofia, Forslind Kristina, Andersson Maria, Gjertsson Inger
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
Department of Medicine Huddinge, Division of Gastroenterology and Rheumatology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Open Access Rheumatol. 2022 Sep 22;14:187-194. doi: 10.2147/OARRR.S372724. eCollection 2022.
Correct diagnosis of early rheumatoid arthritis (RA) is essential for optimal treatment choices. No pathognomonic test is available, and diagnosis is based on classification criteria, which can result in misdiagnosis. Here, we examined the differences between actual and misdiagnosed RA cases in a long-term cohort of patients included based on the ACR-1987 classification criteria.
Patients in the BARFOT (Better Anti-Rheumatic PharmacOTherapy) cohort (n=2543) with at least four follow-up visits during the initial 5 years from enrolment were assessed, and a change in diagnosis was reported by the treating rheumatologist. The groups were analysed with respect to the individual classification criteria, antibodies to citrullinated proteins (ACPA), disease activity (DAS28) and radiographic changes from inclusion up to 2 years.
Forty-five patients (1.8%) were misdiagnosed ( group). When compared to those in the group, the patients who kept their diagnosis () were more often RF positive (64% vs 21%, p<0.001) or ACPA positive (59% vs 8%, p<0.001). They were also more likely to fulfil more than four ACR-1987 criteria (64% vs 33%, p<0.001) and to have radiographic changes at inclusion ( 27% vs 12%, p=0.04). The groups had a similar evolution of DAS28 and its components as well as of radiological joint destruction.
Diagnosis of RA according to the ACR-1987 criteria had a high precision in this long-term cohort. A diagnosis of RA should be re-evaluated in patients who do not fulfil more than four ACR-1987 criteria especially in patients negative for RF.
正确诊断早期类风湿关节炎(RA)对于做出最佳治疗选择至关重要。目前尚无特异性诊断试验,诊断基于分类标准,这可能导致误诊。在此,我们在一个根据美国风湿病学会(ACR)1987年分类标准纳入的长期患者队列中,研究了实际诊断为RA的病例与误诊为RA的病例之间的差异。
对BARFOT(更好的抗风湿药物治疗)队列中的患者(n = 2543)进行评估,这些患者在入组后的最初5年内至少接受了4次随访,并且由治疗的风湿病学家报告诊断变化。根据个体分类标准、抗瓜氨酸化蛋白抗体(ACPA)、疾病活动度(DAS28)以及从入组到2年的影像学变化对两组进行分析。
45例患者(1.8%)被误诊(误诊组)。与误诊组相比,维持原诊断的患者(确诊组)更常出现类风湿因子(RF)阳性(64%对21%,p<0.001)或ACPA阳性(59%对8%,p<0.001)。他们也更有可能满足超过4条ACR - 1987标准(64%对33%,p<0.001),并且在入组时出现影像学改变(27%对12%,p = 0.04)。两组在DAS28及其组成部分以及放射学关节破坏方面的演变相似。
在这个长期队列中,根据ACR - 1987标准诊断RA具有较高的准确性。对于未满足超过4条ACR - 1987标准的患者,尤其是RF阴性的患者,应重新评估RA的诊断。